Published in Science on October 06, 2000
Take five--BACE and the gamma-secretase quartet conduct Alzheimer's amyloid beta-peptide generation. EMBO J (2004) 2.72
Trafficking and proteolytic processing of APP. Cold Spring Harb Perspect Med (2012) 2.56
MicroRNA-298 and microRNA-328 regulate expression of mouse beta-amyloid precursor protein-converting enzyme 1. J Biol Chem (2008) 1.86
The Alzheimer's disease beta-secretase enzyme, BACE1. Mol Neurodegener (2007) 1.81
Targeting the β secretase BACE1 for Alzheimer's disease therapy. Lancet Neurol (2014) 1.76
beta-Secretase as a therapeutic target for Alzheimer's disease. Neurotherapeutics (2008) 1.74
The role of amyloid precursor protein processing by BACE1, the beta-secretase, in Alzheimer disease pathophysiology. J Biol Chem (2008) 1.57
Neurogenesis and Alzheimer's disease: at the crossroads. Exp Neurol (2009) 1.54
Function, therapeutic potential and cell biology of BACE proteases: current status and future prospects. J Neurochem (2014) 1.37
Treatment strategies targeting amyloid β-protein. Cold Spring Harb Perspect Med (2012) 1.37
Developing β-secretase inhibitors for treatment of Alzheimer's disease. J Neurochem (2011) 1.37
BACE1 inhibitor drugs in clinical trials for Alzheimer's disease. Alzheimers Res Ther (2014) 1.30
Alzheimer disease therapy: can the amyloid cascade be halted? J Clin Invest (2003) 1.19
BACE1 (β-secretase) inhibitors for the treatment of Alzheimer's disease. Chem Soc Rev (2014) 1.14
Heparan sulfate regulates amyloid precursor protein processing by BACE1, the Alzheimer's beta-secretase. J Cell Biol (2003) 1.11
Gamma-secretase inhibition and modulation for Alzheimer's disease. Curr Alzheimer Res (2008) 1.09
The Membrane-Bound Aspartyl Protease BACE1: Molecular and Functional Properties in Alzheimer's Disease and Beyond. Front Physiol (2012) 1.09
Membrane proteases in the bacterial protein secretion and quality control pathway. Microbiol Mol Biol Rev (2012) 1.08
Harnessing nature's insight: design of aspartyl protease inhibitors from treatment of drug-resistant HIV to Alzheimer's disease. J Med Chem (2009) 1.05
Potent memapsin 2 (beta-secretase) inhibitors: design, synthesis, protein-ligand X-ray structure, and in vivo evaluation. Bioorg Med Chem Lett (2008) 1.04
Crystal structure of an active form of BACE1, an enzyme responsible for amyloid beta protein production. Mol Cell Biol (2008) 1.02
Analysis of crystal structures of aspartic proteinases: on the role of amino acid residues adjacent to the catalytic site of pepsin-like enzymes. Protein Sci (2001) 1.00
Assigning the protonation states of the key aspartates in β-Secretase using QM/MM X-ray structure refinement. J Chem Theory Comput (2006) 0.98
Design, synthesis and X-ray structure of protein-ligand complexes: important insight into selectivity of memapsin 2 (beta-secretase) inhibitors. J Am Chem Soc (2006) 0.97
What have we learned from the streptozotocin-induced animal model of sporadic Alzheimer's disease, about the therapeutic strategies in Alzheimer's research. J Neural Transm (Vienna) (2012) 0.97
beta-Secretase inhibitor potency is decreased by aberrant beta-cleavage location of the "Swedish mutant" amyloid precursor protein. J Biol Chem (2009) 0.96
Investigation of protein refolding using a fractional factorial screen: a study of reagent effects and interactions. Protein Sci (2005) 0.95
Inhibition of BACE1 for therapeutic use in Alzheimer's disease. Int J Clin Exp Pathol (2010) 0.92
Beta-secretase: structure, function, and evolution. CNS Neurol Disord Drug Targets (2008) 0.92
Consequences of individual N-glycan deletions and of proteasomal inhibition on secretion of active BACE. Mol Biol Cell (2008) 0.90
Protein flexibility in virtual screening: the BACE-1 case study. J Chem Inf Model (2012) 0.90
The Basic Biology of BACE1: A Key Therapeutic Target for Alzheimer's Disease. Curr Genomics (2007) 0.90
β-Secretase: its biology as a therapeutic target in diseases. Trends Pharmacol Sci (2013) 0.88
Inhibition of beta-secretase in vivo via antibody binding to unique loops (D and F) of BACE1. J Biol Chem (2011) 0.86
Beta-amyloid production, aggregation, and clearance as targets for therapy in Alzheimer's disease. Cell Mol Neurobiol (2002) 0.86
Amyloid at the cutting edge: activation of alpha-secretase prevents amyloidogenesis in an Alzheimer disease mouse model. J Clin Invest (2004) 0.86
Spotlight on BACE: the secretases as targets for treatment in Alzheimer disease. J Clin Invest (2001) 0.86
Downregulated miR-29c correlates with increased BACE1 expression in sporadic Alzheimer's disease. Int J Clin Exp Pathol (2015) 0.85
Capturing the essence of organic synthesis: from bioactive natural products to designed molecules in today's medicine. J Org Chem (2010) 0.85
Delta-secretase cleaves amyloid precursor protein and regulates the pathogenesis in Alzheimer's disease. Nat Commun (2015) 0.85
Mechanism of NS2B-mediated activation of NS3pro in dengue virus: molecular dynamics simulations and bioassays. J Virol (2008) 0.84
Predicting memapsin 2 (β-secretase) hydrolytic activity. Protein Sci (2010) 0.84
Structure-based design of highly selective β-secretase inhibitors: synthesis, biological evaluation, and protein-ligand X-ray crystal structure. J Med Chem (2012) 0.84
Neuronal death in Alzheimer's disease and therapeutic opportunities. J Cell Mol Med (2009) 0.84
BACE1 protein endocytosis and trafficking are differentially regulated by ubiquitination at lysine 501 and the Di-leucine motif in the carboxyl terminus. J Biol Chem (2012) 0.84
Organic carbamates in drug design and medicinal chemistry. J Med Chem (2015) 0.83
Drug development for Alzheimer's disease: recent progress. Exp Neurobiol (2010) 0.82
The role of tyrosine 71 in modulating the flap conformations of BACE1. Proteins (2011) 0.81
Recent development of multifunctional agents as potential drug candidates for the treatment of Alzheimer's disease. Curr Med Chem (2015) 0.81
Selective amyloid-beta lowering agents. BMC Neurosci (2008) 0.80
The role of beta-amyloid protein in synaptic function: implications for Alzheimer's disease therapy. Curr Neuropharmacol (2006) 0.80
Enhancement of BACE1 Activity by p25/Cdk5-Mediated Phosphorylation in Alzheimer's Disease. PLoS One (2015) 0.80
Design and characterization of a new cell-permeant inhibitor of the beta-secretase BACE1. Br J Pharmacol (2005) 0.79
L655,240, acting as a competitive BACE1 inhibitor, efficiently decreases β-amyloid peptide production in HEK293-APPswe cells. Acta Pharmacol Sin (2012) 0.79
Atomic resolution analysis of the catalytic site of an aspartic proteinase and an unexpected mode of binding by short peptides. Protein Sci (2003) 0.79
Swedish mutant APP-based BACE1 binding site peptide reduces APP β-cleavage and cerebral Aβ levels in Alzheimer's mice. Sci Rep (2015) 0.78
Triazolyl tryptoline derivatives as β-secretase inhibitors. Bioorg Med Chem Lett (2010) 0.77
Targeting the γ-/β-secretase interaction reduces β-amyloid generation and ameliorates Alzheimer's disease-related pathogenesis. Cell Discov (2015) 0.77
In silico study of peptide inhibitors against BACE 1. Syst Synth Biol (2015) 0.77
Cellular basis of Alzheimer's disease. Ann Indian Acad Neurol (2010) 0.77
In vivo manifestation of Notch related phenotypes in zebrafish treated with Alzheimer's amyloid reducing gamma-secretase inhibitors. J Neurochem (2010) 0.77
Application of computational methods for the design of BACE-1 inhibitors: validation of in silico modelling. Int J Mol Sci (2014) 0.77
Fragment-guided approach to incorporating structural information into a CoMFA study: BACE-1 as an example. J Comput Aided Mol Des (2010) 0.77
From BACE1 inhibitor to multifunctionality of tryptoline and tryptamine triazole derivatives for Alzheimer's disease. Molecules (2012) 0.77
Computational Insights into Substrate and Site Specificities, Catalytic Mechanism, and Protonation States of the Catalytic Asp Dyad of β -Secretase. Scientifica (Cairo) (2014) 0.77
AβPP-selective BACE inhibitors (ASBI): novel class of therapeutic agents for alzheimer's disease. J Alzheimers Dis (2013) 0.76
Current experimental therapy for Alzheimer's disease. Curr Neuropharmacol (2007) 0.76
The Endosome-associated Deubiquitinating Enzyme USP8 Regulates BACE1 Enzyme Ubiquitination and Degradation. J Biol Chem (2016) 0.76
Backbone resonance assignments of the 45.3 kDa catalytic domain of human BACE1. J Biomol NMR (2004) 0.76
Stepping closer to treating Alzheimer's disease patients with BACE1 inhibitor drugs. Transl Neurodegener (2016) 0.76
Exploring the binding of BACE-1 inhibitors using comparative binding energy analysis (COMBINE). BMC Struct Biol (2012) 0.75
Application of a Bioinformatics-Based Approach to Identify Novel Putative in vivo BACE1 Substrates. Biomed Eng Comput Biol (2013) 0.75
Rafts, Nanoparticles and Neural Disease. Nanomaterials (Basel) (2012) 0.75
Physiological Functions of the β-Site Amyloid Precursor Protein Cleaving Enzyme 1 and 2. Front Mol Neurosci (2017) 0.75
Calculation of binding affinities of HIV-1 RT and beta-secretase inhibitors using the linear interaction energy method with explicit and continuum solvation approaches. J Mol Model (2007) 0.75
Efficient screening of marine extracts for protease inhibitors by combining FRET based activity assays and surface plasmon resonance spectroscopy based binding assays. Mar Drugs (2013) 0.75
Structure-based design, synthesis and biological evaluation of novel β-secretase inhibitors containing a pyrazole or thiazole moiety as the P3 ligand. Bioorg Med Chem Lett (2014) 0.75
Conformational Dynamics and Binding Free Energies of Inhibitors of BACE-1: From the Perspective of Protonation Equilibria. PLoS Comput Biol (2015) 0.75
Camel and bovine chymosin: the relationship between their structures and cheese-making properties. Acta Crystallogr D Biol Crystallogr (2013) 0.75
Structure-activity relationship of memapsin 2: implications on physiological functions and Alzheimer's disease. Acta Biochim Biophys Sin (Shanghai) (2013) 0.75
Structure-based design, synthesis, and biological evaluation of dihydroquinazoline-derived potent β-secretase inhibitors. Bioorg Med Chem Lett (2012) 0.75
Targeting mRNA for Alzheimer's and related dementias. Scientifica (Cairo) (2014) 0.75
Splice variants of the Alzheimer's disease beta-secretase, BACE1. Neurogenetics (2012) 0.75
Fragment Binding to β-Secretase 1 without Catalytic Aspartate Interactions Identified via Orthogonal Screening Approaches. ACS Omega (2017) 0.75
Determination of the protonation state of the Asp dyad: conventional molecular dynamics versus thermodynamic integration. J Mol Model (2016) 0.75
Unveiling a novel transient druggable pocket in BACE-1 through molecular simulations: Conformational analysis and binding mode of multisite inhibitors. PLoS One (2017) 0.75
Retrospective molecular docking study of WY-25105 ligand to β-secretase and bias of the three-dimensional structure flexibility. J Mol Model (2013) 0.75
Sequence, Structural Analysis and Metrics to Define the Unique Dynamic Features of the Flap Regions Among Aspartic Proteases. Protein J (2017) 0.75
The sequence of the human genome. Science (2001) 101.55
The genome sequence of Drosophila melanogaster. Science (2000) 74.32
Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem (1984) 18.48
The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell (1999) 7.99
TFAR19, a novel apoptosis-related gene cloned from human leukemia cell line TF-1, could enhance apoptosis of some tumor cells induced by growth factor withdrawal. Biochem Biophys Res Commun (1999) 6.33
Transcription profiling-based identification of Staphylococcus aureus genes regulated by the agr and/or sarA loci. J Bacteriol (2001) 5.57
A statistical method for flagging weak spots improves normalization and ratio estimates in microarrays. Physiol Genomics (2001) 4.50
Genetic definition and sequence analysis of Arabidopsis centromeres. Science (1999) 4.20
Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. Science (1997) 4.19
Stress: a factor to be considered in heterotrophic microorganism enumeration from aquatic environments. Appl Microbiol (1974) 4.03
Arginine methylation of STAT1 modulates IFNalpha/beta-induced transcription. Cell (2001) 3.97
Insights into the molecular basis of leukocyte tethering and rolling revealed by structures of P- and E-selectin bound to SLe(X) and PSGL-1. Cell (2000) 3.95
GeneSplicer: a new computational method for splice site prediction. Nucleic Acids Res (2001) 3.71
Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. Am J Hum Genet (2001) 3.51
Genome scan of human systemic lupus erythematosus: evidence for linkage on chromosome 1q in African-American pedigrees. Proc Natl Acad Sci U S A (1998) 3.35
Structure of Rhodopseudomonas sphaeroides R-26 reaction center. FEBS Lett (1986) 3.28
Cryosurgery of genital warts in cases in which podophyllin treatment failed or was contraindicated. Br J Vener Dis (1977) 3.28
Diuretic therapy for hypertension and the risk of primary cardiac arrest. N Engl J Med (1994) 3.04
A stoichiometric complex of neurexins and dystroglycan in brain. J Cell Biol (2001) 2.98
Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid precursor protein. Proc Natl Acad Sci U S A (2000) 2.96
Three-dimensional structure of the alkaline protease of Pseudomonas aeruginosa: a two-domain protein with a calcium binding parallel beta roll motif. EMBO J (1993) 2.80
Dynamics and folding of single two-stranded coiled-coil peptides studied by fluorescent energy transfer confocal microscopy. Proc Natl Acad Sci U S A (2000) 2.75
Complete genome sequence of the shrimp white spot bacilliform virus. J Virol (2001) 2.58
Ser-His-Glu triad forms the catalytic site of the lipase from Geotrichum candidum. Nature (1991) 2.57
Predicting progression to AIDS: combined usefulness of CD4 lymphocyte counts and p24 antigenemia. Am J Med (1990) 2.56
A comprehensive biochemical and genetic analysis of the yeast U1 snRNP reveals five novel proteins. RNA (1998) 2.55
Structural evidence for gene duplication in the evolution of the acid proteases. Nature (1978) 2.47
Crystal structure of human cytosolic phospholipase A2 reveals a novel topology and catalytic mechanism. Cell (1999) 2.45
Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta. EMBO J (2000) 2.41
Association of genetic variation in FTO with risk of obesity and type 2 diabetes with data from 96,551 East and South Asians. Diabetologia (2011) 2.37
Intracellular signalling: PDK1--a kinase at the hub of things. Curr Biol (1999) 2.31
Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy. Diabetes (2001) 2.30
Management of non-specific urethritis in men. Evaluation of six treatment regimens and effect of other factors including alcohol and sexual intercourse. Br J Vener Dis (1978) 2.28
Lower BMI cut-off value to define obesity in Hong Kong Chinese: an analysis based on body fat assessment by bioelectrical impedance. Br J Nutr (2001) 2.25
A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis. Genes Immun (2002) 2.21
Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer's disease. J Clin Invest (1999) 2.21
Sequence and analysis of chromosome 3 of the plant Arabidopsis thaliana. Nature (2000) 2.17
Susceptibility mapping as a means to visualize veins and quantify oxygen saturation. J Magn Reson Imaging (2010) 2.15
DQ (rather than DR) gene marks susceptibility to narcolepsy. Lancet (1992) 2.08
Visceral leishmaniasis: an unusual case of fever in a renal transplant recipient. Nephrol Dial Transplant (1991) 2.07
Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia. Invest Ophthalmol Vis Sci (2000) 2.06
An enhancer screen identifies a gene that encodes the yeast U1 snRNP A protein: implications for snRNP protein function in pre-mRNA splicing. Genes Dev (1993) 2.03
Latent variable models for longitudinal data with multiple continuous outcomes. Biometrics (2000) 2.02
LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptors. Neuropharmacology (1998) 1.98
Heparan sulfate proteoglycans are critical for the organization of the extracellular distribution of Wingless. Development (2001) 1.96
HLA-B*5703 independently associated with slower HIV-1 disease progression in Rwandan women. AIDS (1999) 1.96
Prospective comparison treatment of 595-nm pulsed-dye lasers for virgin port-wine stain. Br J Dermatol (2015) 1.96
Prevalence of Staphylococcus aureus carrying Panton-Valentine leukocidin genes among isolates from hospitalised patients in China. Clin Microbiol Infect (2008) 1.95
The recovery of cognitive function after general anesthesia in elderly patients: a comparison of desflurane and sevoflurane. Anesth Analg (2001) 1.92
Integrin and cadherin synergy regulates contact inhibition of migration and motile activity. J Cell Biol (1998) 1.91
Evolution in the structure and function of aspartic proteases. J Cell Biochem (1987) 1.90
Detection of herpes simplex viral DNA in the iridocorneal endothelial syndrome. Arch Ophthalmol (1994) 1.88
Evolution of beta-cell dysfunction in the male Zucker diabetic fatty rat. Diabetes (1995) 1.87
Structure of the lipopolysaccharide from an Escherichia coli heptose-less mutant. I. Chemical degradations and identification of products. J Biol Chem (1979) 1.86
Sequence and analysis of chromosome 1 of the plant Arabidopsis thaliana. Nature (2000) 1.85
Differential effects of BMI on diabetes risk among black and white Americans. Diabetes Care (1998) 1.84
The pivotal role of c-Jun NH2-terminal kinase-mediated Beclin 1 expression during anticancer agents-induced autophagy in cancer cells. Oncogene (2008) 1.79
Neurovascular protection reduces early brain injury after subarachnoid hemorrhage. Stroke (2004) 1.79
Human T-cell leukemia virus type 1 Tax induction of NF-kappaB involves activation of the IkappaB kinase alpha (IKKalpha) and IKKbeta cellular kinases. Mol Cell Biol (1998) 1.79
Unusual sites of arginine methylation in Poly(A)-binding protein II and in vitro methylation by protein arginine methyltransferases PRMT1 and PRMT3. J Biol Chem (1999) 1.77
Production of monoclonal antibodies against human epithelial membrane antigen for use in diagnostic immunocytochemistry. Br J Cancer (1985) 1.76
Correlation of cilofungin in vivo efficacy with its activity against Aspergillus fumigatus (1,3)-beta-D-glucan synthase. FEMS Microbiol Lett (1993) 1.74
Hepatitis C virus NS5A physically associates with p53 and regulates p21/waf1 gene expression in a p53-dependent manner. J Virol (2001) 1.73
Activation of Trp3 by inositol 1,4,5-trisphosphate receptors through displacement of inhibitory calmodulin from a common binding domain. Proc Natl Acad Sci U S A (2001) 1.70
Identification of bloodmeals in haematophagous Diptera by cytochrome B heteroduplex analysis. Med Vet Entomol (1999) 1.69
Crystal structure of the catalytic domain of human plasmin complexed with streptokinase. Science (1998) 1.68
Antibody to caspase-cleaved actin detects apoptosis in differentiated neuroblastoma and plaque-associated neurons and microglia in Alzheimer's disease. Am J Pathol (1998) 1.67
Phospholipase D1: a key factor for the exocytotic machinery in neuroendocrine cells. EMBO J (2001) 1.67
Abnormal regulation of DNA methyltransferase expression during colorectal carcinogenesis. Cancer Res (1999) 1.65
Lysosomal enzyme phosphorylation. Recognition of a protein-dependent determinant allows specific phosphorylation of oligosaccharides present on lysosomal enzymes. J Biol Chem (1984) 1.64
Kinetic studies of human immunodeficiency virus type 1 protease and its active-site hydrogen bond mutant A28S. J Biol Chem (1991) 1.64
A cohort study of cancer among benzene-exposed workers in China: overall results. Am J Ind Med (1996) 1.63
Transfer of the excitation energy in Anacystis nidulans grown to obtain different pigment ratios. Biophys J (1966) 1.63
Glial fibrillary acidic protein-apolipoprotein E (apoE) transgenic mice: astrocyte-specific expression and differing biological effects of astrocyte-secreted apoE3 and apoE4 lipoproteins. J Neurosci (1998) 1.61
Cell-specific signal transduction of parathyroid hormone (PTH)-related protein through stably expressed recombinant PTH/PTHrP receptors in vascular smooth muscle cells. Endocrinology (1996) 1.61
Acetylcholine, outer hair cell electromotility, and the cochlear amplifier. J Neurosci (1997) 1.61
Consistent associations of HLA class I and II and transporter gene products with progression of human immunodeficiency virus type 1 infection in homosexual men. J Infect Dis (1999) 1.60
Identification and functional analysis of mutations in the hypocretin (orexin) genes of narcoleptic canines. Genome Res (2001) 1.59
The Drosophila sugarless gene modulates Wingless signaling and encodes an enzyme involved in polysaccharide biosynthesis. Development (1997) 1.59
CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia. Cancer Epidemiol Biomarkers Prev (1998) 1.59
Permeability and enterotoxic factors of nonagglutinable vibrios Vibrio alcaligenes and Vibrio parahaemolyticus. Appl Microbiol (1971) 1.58
Cloning and characterization of the Bacteroides fragilis metalloprotease toxin gene. Infect Immun (1997) 1.58
Familial hypobetalipoproteinemia: genetics and metabolism. Cell Mol Life Sci (2005) 1.58
Effect of point mutations on the kinetics and the inhibition of human immunodeficiency virus type 1 protease: relationship to drug resistance. Biochemistry (1995) 1.56
Lysyl oxidase and rrg messenger RNA. Science (1991) 1.55
Activation of a cell-cycle-regulated histone gene by the oncogenic transcription factor IRF-2. Nature (1995) 1.54
Congenital neuromuscular disease with uniform type 1 fiber and RYR1 mutation. Neurology (2007) 1.53
Pharmacokinetics/genotype associations for major cytochrome P450 enzymes in native and first- and third-generation Japanese populations: comparison with Korean, Chinese, and Caucasian populations. Clin Pharmacol Ther (2008) 1.53
The 90-kDa ribosomal S6 kinase (pp90rsk) phosphorylates the N-terminal regulatory domain of IkappaBalpha and stimulates its degradation in vitro. J Biol Chem (1997) 1.53
Stigmatization and shame: consequences of caring for HIV/AIDS patients in China. AIDS Care (2007) 1.53
Natural CD8+CD122+ T cells are more potent in suppression of allograft rejection than CD4+CD25+ regulatory T cells. Am J Transplant (2013) 1.52
Crystal structure of an in vivo HIV-1 protease mutant in complex with saquinavir: insights into the mechanisms of drug resistance. Protein Sci (2000) 1.52
High-performance affinity beads for identifying drug receptors. Nat Biotechnol (2000) 1.52